Posted
Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will now seek approval for an Alzheimer's drug after abandoning the drug earlier this year.
03:26
01:41
02:15
01:16
01:21
01:45
01:16
00:58
00:35
01:09
01:32
02:00
01:07
01:34
02:00
02:19
01:18
02:06
02:01
01:14
02:02
01:35
01:42
02:28
02:26
01:19
01:23
01:35
02:00
01:21
01:26
01:00
01:03
00:59
01:48
01:55
00:59
01:53
01:03
02:16
00:56
01:20
01:55
03:03
01:16
01:19
01:46
03:08
01:31
01:54
02:20
00:39
01:50
02:01
00:35
03:22
01:44
02:25
01:42
01:42
01:17
01:16
00:59
01:19
02:07
02:22
02:01
02:05
01:01
00:58
01:45
01:29
00:59
00:53
01:54
01:00
01:25
02:00
01:14
00:53
02:04
00:58
01:01
01:10
01:26
01:13
00:58
01:31
01:11
01:03
00:30
01:24
01:20
01:02
01:41
01:19
01:18
01:45